← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 6, 2020Last known activity
Jan 1, 2026
Timeline
No events for the selected filters.
Drugs by trial phase (30 distinct, 19 trials)
Phase 4 (10 own, 0 via acquisition)
Phase 3 (11 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Recent trials (23)
- NCT07288749CollaboratorPhase 3Jan 1, 2026
- NCT07240467CollaboratorPhase 2/Phase 3Dec 15, 2025
- NCT07152639CollaboratorPhase 3Aug 9, 2025
- NCT07019012CollaboratorPhase 4Jul 30, 2025
- NCT07048353CollaboratorEarly Phase 1Jul 28, 2025
- NCT07077486CollaboratorPhase 4Jul 25, 2025
- NCT07002346CollaboratorPhase 3Jun 1, 2025
- NCT06641778Lead sponsorN/AOct 28, 2024
- NCT06641778OfficialN/AOct 28, 2024
- NCT06641778Sponsor investigatorN/AOct 28, 2024
- NCT06470256CollaboratorPhase 1Jun 1, 2024
- NCT06265051CollaboratorPhase 2/Phase 3Apr 9, 2024
- NCT06236022CollaboratorPhase 4Jan 1, 2024
- NCT05672420CollaboratorPhase 1/Phase 2Jan 1, 2023
- NCT05329155CollaboratorN/AJul 20, 2022
Details
- Last known activity
- Jan 1, 2026